L-Deprenyl fails to protect mesencephalic dopamine neurons and PC12 cells from the neurotoxic effect of 1-methyl-4-phenylpyridinium ion

Brain Research

Volumn 741, Issue 1-2, 1996, Pages 68-74

  Vaglini, Francesca ^a,b   Pardini, Carla ^a   Cavalletti, Micaela ^a   Maggio, Roberto ^a   Corsini, Giovanni U ^a  

^a UNIVERSITY OF PISA   (Italy)

^b Associazione 'Anni Verdi'   (Italy)

Author keywords

1 methyl 4 phenyl pyridinium ion (MPP+); L deprenyl; mesencephalic cells; PC12

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; DOPAMINE; NEUROPROTECTIVE AGENT; SELEGILINE; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; EMBRYO; IMMUNOCYTOCHEMISTRY; MESENCEPHALON; MOUSE; NEUROTOXICITY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL;

1-METHYL-4-PHENYLPYRIDINIUM; ANIMALS; CELL DEATH; CELLS, CULTURED; CHOLINE; DOPAMINE; DOPAMINE AGENTS; DOPAMINE ANTAGONISTS; IMMUNOHISTOCHEMISTRY; MESENCEPHALON; MICE; MONOAMINE OXIDASE INHIBITORS; NEURONS; PC12 CELLS; RATS; SELEGILINE; TYROSINE 3-MONOOXYGENASE;

EID: 0030601953     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(96)00898-0     Document Type: Article

References (33)

1. [1] Bennett, B.A., Hyde, C.E., Pecora, J.R. and Clodfelter, J.E., Differing neurotoxic potencies of methamphetamine, mazindol, and cocaine on mesencephalic cultures, J. Neurochem., 60 (1993) 1444-1452.
2. [2] Biagini, G., Zoli, M., Fuxe, K. and Agnati, L.F., L-Deprenyl increases GFAP immunoreactivity selectively in activated astrocytes in rat brain, NeuroReport, 4 (1993) 955-958.
3. [3] Birkmayer, W., Riederer, P., Youdim, M.B.H. and Linauet, W., The potentiation of the anti-akinetic effect of L-dopa treatment by an inhibitor of MAO-B, L-deprenyl, J. Neural Transm., 36 (1975) 303-336.
4. [4] Cohen, G. and Mytilineou, C., Studies on the mechanism of action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), Life Sci., 36 (1985) 237-242.
5. +), Biochem. Biophys. Res. Commun., 181 (1991) 1442-1448.
6. [6] Driscoll, B.F., Law, M.J. and Crane, A.M., Cell damage associated with changing the medium of mesencephalic cultures in serum-free medium is mediated via N-methyl-D-aspartate receptors, J. Neurochem., 56 (1991) 1201-1206.
7. [7] Engele, J. and Bohn, M.C., The neurotrophic effects of fibroblast growth factors on dopaminergic neurons in vitro are mediated by mesencephalic glia, J. Neurosci., 11 (1991) 3070-3078.
8. [8] Fallon, J.M. and Loughlin, S.E., Substantia nigra. In G., Paxinos (Ed.), The Rat Nervous System Academic Press, Orlando, FL, 1985, pp. 353-374.
9. [9] Johannessen, J.N., Chiueh, C.C., Burns, R.S. and Markey, S.P., Differences in the metabolism of MPTP in the rodent and primate parallel differences in sensitivity to its neurotoxic effects, Life Sci., 36 (1985) 219-224.
10. [10] Ju, W.J.H., Holland, D.P. and Tatton, W.G., (-)-Deprenyl alters the time course of death of axotomized facial motoneurons and the hypertrophy of neighboring astrocytes in immature rats, Exp. Neurol., 126 (1994) 233-246.
11. +), J. Neural. Transm. (Gen. Sect.), 94 (1993) 189.
12. +-treated dopaminergic neurons, Eur. J. Pharmacol., 269 (1994) R3-R4.
13. [13] Langston, J.W., Ballard, P.A., Tetrud, J.W. and Irwin, I., Chronic parkinsonism in human due to a product of meperidine-analog synthesis, Science, 219 (1983) 979-980.
14. [14] Li, X.M., Juorio, A.V., Paterson, I.A., Zhu, M.Y. and Boulton, A.A., Specific irreversible monoamine oxidase-B inhibitors stimulate gene expression of aromatic L-amino acid decarboxilase in PC12-cells, J. Neurochem., 59 (1992) 2324-2327.
15. [15] Li, X.M., Qi, J., Juorio, A.V. and Boulton, A.A., Reduction in glial fibrillary acidic protein messenger RNA abundance induced by (-)-deprenyl and other monoamine oxidase-B-inhibitors in C6 glioma cells, J. Neurochem., 61 (1993) 1573-1576.
16. [16] Lindvall, O. and Bjorklund, A., Dopamine- and norepinephrine-containing neurons system: their anatomy in the rat brain. In P.C., Emson (Ed.), Chemical Neuroanatomy, Raven Press, New York, 1983, pp. 229-255.
17. [17] Lowry, O.H., Rosenbrough, N.J., Farr, A.L. and Randall, R.J., Protein measurement with the Folin phenol reagent, J. Biol. Chem., 193 (1951) 265-275.
18. [18] Manthorpe, M., Rudge, J.S. and Varon, S., Astroglial cell contributions to neuronal survival and neuritic growth. In S. Fedoroff and A. Vernadakis (Eds.), Astrocytes, Vol. 2, Academic Pess, New York, 1986, pp. 315-376.
19. [19] Mytilineou, C. and Cohen, G., 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine destroys dopamine neurons in explants of rat embryo mesencephalon, Science, 225 (1984) 529-531.
20. [20] Mytilineou, C. and Cohen, G., Deprenyl protects dopamine neurons from the neurotoxic effect of 1-methyl-4-phenylpyridinium ion, J. Neurochem., 45 (1985) 1951-1953.
21. + ) is toxic to mesencephalic dopamine neurons in culture, Neurosci. Lett., 57 (1985) 19-24.
22. [22] Nicklas, W.J., Vyas, I. and Heikkila, R.E., Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenylpyridine, a metabolite of the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, Life Sci., 36 (1985) 2503-2508.
23. [23] Oh, C., Murray, B., Bhattacharya, N., Holland, D. and Tatton, W.G., ( - )-Deprenyl alters the survival of adult facial motoneurons after axotomy: increases in vulnerable C57BL strain but decreases in Mnd mutants, J. Neurosci. Res., 38 (1993) 64-74.
24. [24] Parkinson S.G., Effect of deprenyl on the progression of disability in early Parkinson's disease, N. Engl. J. Med., 321 (1989) 1364-1371.
25. [25] Poungvarin, N. and Viriyavejakul, A., L-Deprenyl therapy in Thai patients with Parkinson's disease before and after clinical trial of 50 patients, J. Med. Assoc. Thail., 73 (1990)381-386.
26. [26] Prochiantz, A., Di Porzio, U., Kato, A., Berger, B., Glowinsky, J., In vitro maturation of mesencephalic dopaminergic neurons from mouse embryos is enhanced in presence of their striatal target cells, Proc. Natl. Acad. Sci. USA, 76 (1979) 5387-5391.
27. +) but not 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) selectively destroys dopaminergic neurons in cultures of dissociated rat mesencephalic neurons, Neurosci. Lett., 72 (1986) 215-220.
28. [28] Sanchez-Ramos, J., Michel, P., Weiner, W.J. and Hefti, F., Selective destruction of cultured dopaminergic neurons from fetal rat mesencephalon by 1-methyl-4-phenylpyridinium: cytochemical and morphological evidence, J. Neurochem., 50 (1988) 1934-1944.
29. [29] Seniuk, N.A., Henderson, J.T., Tatton, W.G. and Roder, J.C., Increased CNTF gene expression in process bearing astrocytes following injury is augmented by R-( - )-deprenyl, J. Neurosci. Res., 37 (1994) 278-276.
30. [30] Tatton, W.G., Ju, W.J.H., Holland, D.P., Tai, C. and Kwan, M., (-)-Deprenyl reduces PC12 cell apoptosis by inducing new protein synthesis, J. Neurochem., 63 (1994) 1572-1575.
31. [31] Tetrud, J.W. and Langston, J.W., The effect of deprenyl (selegiline) on the natural history of Parkinson's disease, Science, 245 (1989) 519-522.
32. [32] Vaglini, F., Fascetti, F., Fornai, F., Maggio, R. and Corsini, G.U., ( + )MK-801 prevents the DDC-induced enhancement of MPTP toxicity in mice, Brain Res., 668 (1994) 194-203.
33. [33] Vaglini, F., Pardini, C., Maggio, R. and Corsini, G.U., Role of excitatory amino acids in diethyldithiocarbamate-induced cell death in mesencephalic cultures. Brain Res., 674 (1995) 127-132.